Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × Aspirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 4 Multiple Myeloma 3 Barrett Esophagus 3 Venous Thromboembolism 2 Precancerous Conditions 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Vascular Diseases 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Thromboembolism 1 Thrombocytopenia 1 Stroke 1 Soft Tissue Neoplasms 1 Smoking Cessation 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Pulmonary Nodules 1 Melanoma 1

Interventions

Prednisone 101 Docetaxel 79 Leuprolide 72 Abiraterone Acetate 62 enzalutamide 59 bicalutamide 44 Goserelin 44 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 38 Radiotherapy 33 gallium 68 PSMA-11 21 apalutamide 21 abiraterone 21 Magnetic Resonance Spectroscopy 21 Gonadotropin-Releasing Hormone 21 luprolide acetate gel depot 19 sipuleucel-T 18 Androgen Antagonists 18 Triptorelin Pamoate 17 Radiosurgery 17 cabazitaxel 15 Radiotherapy, Intensity-Modulated 14 pembrolizumab 13 cabozantinib 13 Prednisolone 12 Flutamide 12 Dexamethasone 12 Brachytherapy 12 radium Ra 223 dichloride 11 fluciclovine F-18 11 Radiation 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03103152 2023-03-29

PROVENT

Queen Mary University of London

Phase 2/3 Completed

104 enrolled 14 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡